Ginkgo Bioworks reports Q3 2026 results, announces first autonomous lab sale to NovoNov 5Quarterly updateGinkgo Bioworks Holdings, Inc.Novo Nordisk A/SUpdated
IDEAYA completes darovasertib NDA, halts Phase 3 OptimUM-010 for enrollment issuesNov 3Quarterly updateAlector, Inc.Allogene Therapeutics
Harmony Biosciences names Peter Anastasiou CEO, succeeding Jeffrey DaynoOct 13PeopleHarmony Biosciences Holdings, Inc.pitolisant
Sign in